Retatrutide

Retatrutide is a triple agonist peptide that targets three different kinds of hormone receptors. These are glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. This distinguishes it from other agonists that target just one or two receptors and forms the basis of research into its pharmacological properties. [1] This topic is important in metabolic and cardiometabolic research, as it activates all three receptor systems. Studies are being conducted to understand how the signaling systems of the three receptors may help analyze the processes associated with energy balance and metabolic control. Other areas of research include lipid metabolism and liver-related metabolic pathways. Ongoing research also examines the GIP, GLP-1, and glucagon receptor systems to better understand how these metabolic pathways interact and contribute to the regulation of energy balance and metabolic homeostasis.